Human endometrial regenerative cells attenuate renal ischemia reperfusion injury in mice
Open Access
- 28 January 2016
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 14 (1) , 1-13
Abstract
Endometrial regenerative cells (ERCs) is an attractive novel type of adult mesenchymal stem cells that can be non-invasively obtained from menstrual blood and are easily replicated at a large scale without tumorigenesis. We have previously reported that ERCs exhibit unique immunoregulatory properties in experimental studies in vitro and in vivo. In this study, the protective effects of ERCs on renal ischemia–reperfusion injury (IRI) were examined. Renal IRI in C57BL/6 mice was induced by clipping bilateral renal pedicles for 30 min, followed by reperfusion for 48 h. ERCs were isolated from healthy female menstrual blood, and were injected (1 million/mouse, i.v.) into mice 2 h prior to IRI induction. Renal function, pathological and immunohistological changes, cell populations and cytokine profiles were evaluated after 48 h of renal reperfusion. Here, we showed that as compared to untreated controls, administration of ERCs effectively prevented renal damage after IRI, indicated by better renal function and less pathological changes, which were associated with increased serum levels of IL-4, but decreased levels of TNF-α, IFN-γ and IL-6. Also, ERC-treated mice displayed significantly less splenic and renal CD4+ and CD8+ T cell populations, while the percentage of splenic CD4+CD25+ regulatory T cells and infiltrating M2 macrophages in the kidneys were significantly increased in ERC-treated mice. This study demonstrates that the novel anti-inflammatory and immunoregulatory effects of ERCs are associated with attenuation of renal IRI, suggesting that the unique features of ERCs may make them a promising candidate for cell therapies in the treatment of ischemic acute kidney injury in patients.Keywords
Funding Information
- National Natural Science Foundation of China (81273257, 81471584)
- Li Jieshou Intestinal Barrier Research Special Fund (LJS-201412)
- Tianjin Application Basis and Cutting-Edge Technology Research Grant (14JCZDJC35700)
This publication has 72 references indexed in Scilit:
- Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactionsKidney International, 2013
- Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injuryKidney International, 2012
- Role of reactive oxygen and nitrogen species in the vascular responses to inflammationFree Radical Biology and Medicine, 2012
- Colony-Stimulating Factor-1 Promotes Kidney Growth and Repair via Alteration of Macrophage ResponsesThe American Journal of Pathology, 2011
- Macrophages Expressing Heme Oxygenase-1 Improve Renal Function in Ischemia/Reperfusion InjuryMolecular Therapy, 2010
- Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidneyKidney International, 2010
- Macrophages, Dendritic Cells, and Kidney Ischemia-Reperfusion InjurySeminars in Nephrology, 2010
- The innate immune response in ischemic acute kidney injuryClinical Immunology, 2009
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005